Genetic Architecture of 11 Major Psychiatric Disorders at Biobehavioral, Functional Genomic, and Molecular Genetic Levels of Analysis - Grotzinger, Andrew D.; Mallard, Travis T.; Akingbuwa, Wonuola A.; Ip, Hill F.; Adams, Mark J.; Lewis, Cathryn M.; McIntosh, Andrew M.; Grove, Jakob; Dalsgaard, Søren; Lesch, Klaus-Peter; Strom, Nora; Meier, Sandra M.; et al. (medRxiv, 2020)
We systematically interrogate the joint genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic, and molecular genetic levels of analysis. We identify four broad factors (Neurodevelopmental, Compulsive, Psychotic, and Internalizing) that underlie genetic correlations among the disorders, and test whether these factors adequately explain their genetic correlations with biobehavioral traits. We introduce Stratified Genomic Structural Equation Modelling, which we use to identify gene sets and genomic regions that disproportionately contribute to pleiotropy, including protein-truncating variant intolerant genes expressed in excitatory and GABAergic brain cells that are enriched for pleiotropy between disorders with psychotic features. Multivariate association analyses detect a total of 152 (20 novel) independent loci which act on the four factors, and identify nine loci that act heterogeneously across disorders within a factor. Despite moderate to high genetic correlations across all 11 disorders, we find very little utility of, or evidence for, a single dimension of genetic risk across psychiatric disorders.Competing Interest StatementJ.W.S. is an unpaid member of the Bipolar/Depression Research Community Advisory Panel of 23andMe. H.R.K. (Henry R. Kranzler) is a member of the American Society of Clinical Psychopharmacologys Alcohol Clinical Trials Initiative, which was supported in the last three years by AbbVie, Alkermes, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, Pfizer, Arbor, and Amygdala Neurosciences. CML is on the SAB for Myriad Neuroscience. GB is a scientific advisor for COMPASS Pathways. The other authors declare no competing interests.Funding StatementThis work presented here would not have been possible without the enormous efforts put forth by the investigators and participants from Psychiatric Genetics Consortium, iPSYCH, UK Biobank, and 23andMe. The work from these contributing groups was supported by numerous grants from governmental and charitable bodies as well as philanthropic donation. Research reported in this publication was supported by the National Institute Of Mental Health of the National Institutes of Health under Award Number R01MH120219. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ADG was additionally supported by NIH Grant R01HD083613. EMTD was additionally supported by NIH grants R01AG054628 and R01HD083613 and the Jacobs Foundation. EMTD is a faculty associate of the Population Research Center at the University of Texas, which is supported by NIH grant P2CHD042849. MGN is additionally supported by ZonMW grants 849200011 and 531003014 from The Netherlands Organisation for Health Research and Development, a VENI grant awarded by NWO (VI.Veni.191G.030) and is a Jacobs Foundation Fellow. WAA is supported by the "European Unions Horizon 2020 research and innovation programme, Marie Sklodowska Curie Actions MSCA-ITN-2016 Innovative Training Networks under grant agreement No [721567]". HFI is supported by the "Aggression in Children: unraveling gene-environment interplay to inform Treatment and InterventiON strategies" (ACTION) project. ACTION receives funding from the European Union Seventh Framework Program (FP7/2007 to 2013) under grant agreement no 602768. CML is supported by the National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. AMM is supported by the Wellcome Trust (104036/Z/14/Z, 216767/Z/19/Z), UKRI MRC (MC PC 17209, MR/S035818/1). KPL is supported by the Deutsche Forschungsgemeinschaft (DFG: CRU 125, CRC TRR 58 A1/A5, No. 44541416), the European Unions Seventh Framework Programme under Grant No. 602805 (Aggressotype), the Horizon 2020 Research and Innovation Programme under Grant No. 728018 (Eat2beNICE) and 643051 (MiND), Fritz Thyssen Foundation (No. 10.13.1185), ERA Net NEURON/RESPOND, No. 01EW1602B, ERA Net NEURON/DECODE, No. FKZ01EW1902 and 5 100 Russian Academic Excellence Project. GB is supported by the National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. PL is supported by NIH R01MH119243 and R00MH101367.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We have used de-identified GWAS summary statistics for the analyses reported in the current study. For those no IRB oversight is necessary. Summary statistics used in the present analyses are largely publicly available for download using the database links noted in the manuscript. Summary statistics obtained for Major Depressive Disorder and ADHD were obtained from 23andMe after receiving approval for use in the present analyses. 23andMe research is IRB approved and all 23andMe Research participants provided consent for their data to be used in future analyses. A copy of the current 23andMe consent form can be found at: https://www.23andme.com/about/consent/.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are all publicly available or can be requested for access. Specific download links for various datasets are directly below.Summary statistics for data from the PGC can be downloaded or requested here: https://www.med.unc.edu/pgc/download-results/Summary statistics for the Anxiety phenotype in UKB (TotANX_OR) can be downloaded here: https://drive.google.com/drive/folders/1fguHvz7l2G45sbMI9h_veQun4aXNTy1v23andMe summary statistics are made available through 23andMe to qualified researchers under an agreement with 23andMe that protects the privacy of 23andMe participants. Please visit research.23andme.com/collaborate/#publication for more informationSummary statistics for the volume-based neuroimaging phenotypes were downloaded from: https://github.com/BIG-S2/GWASSummary statistics for the health and well-being complex trait correlations can be downloaded from: https://atlas.ctglab.nl/Summary statistics for the circadian rhythm correlations across 24-hours can be downloaded from: https://cnsgenomics.com/software/gcta/#DataResourceData from gnomAD used to identify PI genes for creation of annotations can be downloaded here: https://storage.googleapis.com/gnomad-public/release/2.1.1/constraint/gnomad.v2.1.1.lof_metrics.by_gene.txt.bgzGene count data per cell for creation of annotations were obtained from: https://storage.googleapis.com/gtex_additional_datasets/single_cell_data/GTEx_droncseq_hip_pcf.tarData which maps individual cells to cell types (e.g. neuron, astrocyte etc.) were obtained from: https://static-content.springer.com/esm/art%3A10.1038%2Fnmeth.4407/MediaObjects/41592_2017_BFnmeth4407_MOESM10_ESM.xlsxLinks to the LD-scores, reference panel data, and the code used to produce the current results can all be found at: https://github.com/MichelNivard/GenomicSEM/wikiLinks to the BaselineLD v2.2 annotations can be found here: https://data.broadinstitute.org/alkesgroup/LDSCORE/